tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 330 are a BUY (88.24%), 44 are a HOLD (11.76%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 34.29% that have a potential upside of 57.91% achieved within 128 days.
Emily Bodnar’s has documented 690 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AGEN, Agenus at 11-Aug-2026.
Analyst best performing recommendations are on SQZ (SQZ BIOTECHNOLOGIES CO).
The best stock recommendation documented was for OLMA (OLEMA PHARMACEUTICALS) at 10/20/2025. The price target of $28 was fulfilled within 37 days with a profit of $20.23 (260.36%) receiving and performance score of 70.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Aug-2023
$48
$0.45 (0.95%)
$48
Buy Since 14-Sep-2022
$48
$0.45 (0.95%)
$68
Hold Since 24-May-2023
$48
$0.45 (0.95%)
$38
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
